Clinic
Wyandot Memorial Hospital
Wyandot Memorial Hospital was paid $7.11M by Medicaid between Jan 2018 and Dec 2024, across 183 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 18% of everything it billed.
33Billing provider infoWYANDOT MEMORIAL HOSPITAL
UPPER SANDUSKY, OH 43351
UPPER SANDUSKY, OH 43351
33aNPI1477554475assigned 08/02/2005
33bProvider typeUrgent Care Clinic/Center
28Total paid$7.11M
24GClaims208,373
24DCodes billed183
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Ohio
Rank by total paid#6 of 95
Median peer was paid$201K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,330 | $277K | |
| 2019 | 10,454 | $242K | |
| 2020 | 5,736 | $176K | |
| 2021 | 16,803 | $318K | |
| 2022 | 30,335 | $859K | |
| 2023 | 75,704 | $3.16M | |
| 2024incomplete | 56,011 | $2.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 18% | 12,463 | 8,809 | $1.28M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 27,266 | 22,330 | $905K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.3% | 4,597 | 4,093 | $659K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.2% | 2,964 | 2,342 | $509K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.3% | 1,256 | 801 | $447K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 2,121 | 1,709 | $356K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.9% | 9,650 | 8,204 | $349K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.9% | 3,317 | 815 | $276K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 510 | 424 | $170K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 2,031 | 1,871 | $160K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 518 | 384 | $148K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.0% | 1,296 | 357 | $142K |
171 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.6% | 321 | $117K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 1,301 | $115K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.6% | 454 | $111K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 796 | $111K |
| 80053 | Comprehensive metabolic panel | 1.4% | 7,065 | $100K |
| 0240U | 1.3% | 581 | $93K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 590 | $71K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 917 | $68K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 43 | $67K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,364 | $64K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,268 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 738 | $43K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 206 | $38K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,719 | $32K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 944 | $30K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 696 | $29K |
| 80061 | Lipid panel | <1% | 1,554 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,614 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,784 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 528 | $23K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,346 | $23K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 769 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 664 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,421 | $17K |
| 97016 | <1% | 400 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 395 | $16K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 67 | $15K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 172 | $15K |
| 97162 | <1% | 337 | $15K | |
| 84439 | <1% | 726 | $13K | |
| 82728 | <1% | 572 | $13K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 100 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,553 | $12K |
| 81001 | <1% | 3,308 | $12K | |
| 82607 | <1% | 447 | $11K | |
| 73630 | <1% | 277 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,846 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 866 | $10K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 206 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 395 | $8K |
| 76830 | Ultrasound, transvaginal | <1% | 58 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 808 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 277 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,754 | $7K |
| 87077 | <1% | 588 | $7K | |
| 83735 | <1% | 1,616 | $7K | |
| 83540 | <1% | 511 | $6K | |
| 74018 | <1% | 110 | $6K | |
| 85027 | <1% | 557 | $6K | |
| 73610 | <1% | 90 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 138 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 27 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,508 | $4K |
| 73030 | <1% | 93 | $4K | |
| 96127 | <1% | 195 | $4K | |
| 83550 | <1% | 432 | $4K | |
| 87070 | <1% | 170 | $4K | |
| 87186 | <1% | 585 | $4K | |
| 82570 | <1% | 380 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 206 | $3K |
| 73564 | <1% | 22 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 109 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 77 | $3K |
| 80069 | <1% | 181 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 27 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 56 | $3K |
| 80320 | <1% | 175 | $2K | |
| 80305 | <1% | 362 | $2K | |
| 86803 | <1% | 68 | $2K | |
| 97164 | <1% | 70 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 369 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 20 | $2K |
| 90836 | <1% | 91 | $2K | |
| 85610 | <1% | 976 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 50 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 231 | $2K |
| 83655 | <1% | 48 | $2K | |
| 82746 | <1% | 164 | $2K | |
| 84484 | <1% | 1,235 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,112 | $2K |
| 97014 | <1% | 45 | $2K | |
| 87210 | <1% | 83 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 55 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 277 | $2K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 98 | $2K |
| 59430 | <1% | 38 | $1K | |
| 83690 | <1% | 838 | $1K | |
| 85652 | <1% | 199 | $1K | |
| 81025 | <1% | 668 | $1K | |
| 83970 | <1% | 60 | $1K | |
| 84550 | <1% | 239 | $1K | |
| 0071A | <1% | 20 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 771 | $1K |
| 83880 | <1% | 377 | $956.08 | |
| 86140 | <1% | 62 | $941.08 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 118 | $915.58 |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 18 | $911.23 |
| 85018 | <1% | 139 | $886.48 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 14 | $829.67 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 38 | $797.67 |
| 85730 | <1% | 330 | $778.25 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 30 | $720.42 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 192 | $659.37 |
| 99243 | <1% | 16 | $606.20 | |
| 87081 | <1% | 46 | $594.13 | |
| 99335 | <1% | 35 | $490.32 | |
| 72100 | <1% | 14 | $459.16 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 147 | $425.23 |
| 80076 | <1% | 33 | $395.93 | |
| 73110 | <1% | 12 | $375.94 | |
| 0352U | <1% | 12 | $364.80 | |
| 84100 | <1% | 53 | $363.45 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $325.09 |
| 82248 | <1% | 26 | $321.52 | |
| 99336 | <1% | 85 | $321.13 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 332 | $256.62 |
| 99442 | <1% | 13 | $244.31 | |
| 85379 | <1% | 333 | $209.06 | |
| 84703 | <1% | 160 | $191.72 | |
| 84156 | <1% | 45 | $176.32 | |
| 86038 | <1% | 16 | $171.79 | |
| 51798 | <1% | 40 | $168.45 | |
| 82043 | <1% | 15 | $167.77 | |
| 82150 | <1% | 15 | $166.25 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 199 | $159.99 |
| 73562 | <1% | 12 | $146.17 | |
| 94761 | <1% | 184 | $138.31 | |
| 99152 | <1% | 96 | $135.63 | |
| 11721 | <1% | 26 | $131.33 | |
| 84155 | <1% | 16 | $122.65 | |
| 82948 | <1% | 114 | $103.67 | |
| 83605 | <1% | 545 | $100.33 | |
| 87040 | <1% | 347 | $84.88 | |
| 84165 | <1% | 16 | $79.05 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,245 | $78.96 |
| 96376 | <1% | 74 | $74.92 | |
| 87205 | <1% | 14 | $63.36 | |
| 80329 | <1% | 14 | $60.21 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,730 | $58.51 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,740 | $43.69 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 23 | $41.58 |
| 99173 | <1% | 12 | $19.68 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,967 | $10.99 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 286 | $9.94 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 2,749 | $7.80 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 108 | $3.34 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,001 | $0.84 |
| 91301 | <1% | 19 | $0.13 | |
| 91307 | <1% | 39 | $0.08 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 13,483 | $0.00 |
| 4004F | 0% | 1,593 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 11,248 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,813 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 472 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 83 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 12 | $0.00 |
| 0502F | 0% | 19 | $0.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 17 | $0.00 |
| 3078F | 0% | 17 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 18 | $0.00 |
| 1036F | 0% | 4,224 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 22 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 16 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 764 | $0.00 |
| 3017F | 0% | 365 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 219 | $0.00 |
| A9270 | Non-covered item or service | 0% | 129 | $0.00 |
| 3079F | 0% | 18 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 40 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 147 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNOYES, KENDRA (PRESIDENT AND CEO)
Parent organizationWYANDOT MEMORIAL HOSPITAL